388 related articles for article (PubMed ID: 7912987)
1. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis.
Birrer P; McElvaney NG; Rüdeberg A; Sommer CW; Liechti-Gallati S; Kraemer R; Hubbard R; Crystal RG
Am J Respir Crit Care Med; 1994 Jul; 150(1):207-13. PubMed ID: 7912987
[TBL] [Abstract][Full Text] [Related]
2. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.
Vogelmeier C; Hubbard RC; Fells GA; Schnebli HP; Thompson RC; Fritz H; Crystal RG
J Clin Invest; 1991 Feb; 87(2):482-8. PubMed ID: 1671391
[TBL] [Abstract][Full Text] [Related]
3. Human neutrophil elastase and elastase/alpha 1-antiprotease complex in cystic fibrosis. Comparison with interstitial lung disease and evaluation of the effect of intravenously administered antibiotic therapy.
Meyer KC; Lewandoski JR; Zimmerman JJ; Nunley D; Calhoun WJ; Dopico GA
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):580-5. PubMed ID: 1892298
[TBL] [Abstract][Full Text] [Related]
4. Bronchiolitis obliterans syndrome after (heart-)lung transplantation. Impaired antiprotease defense and increased oxidant activity.
Hirsch J; Elssner A; Mazur G; Maier KL; Bittmann I; Behr J; Schwaiblmair M; Reichenspurner H; Fürst H; Briegel J; Vogelmeier C
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1640-6. PubMed ID: 10556134
[TBL] [Abstract][Full Text] [Related]
5. Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor.
McElvaney NG; Nakamura H; Birrer P; Hébert CA; Wong WL; Alphonso M; Baker JB; Catalano MA; Crystal RG
J Clin Invest; 1992 Oct; 90(4):1296-301. PubMed ID: 1357002
[TBL] [Abstract][Full Text] [Related]
6. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation.
Konstan MW; Hilliard KA; Norvell TM; Berger M
Am J Respir Crit Care Med; 1994 Aug; 150(2):448-54. PubMed ID: 8049828
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of recombinant secretory leukoprotease inhibitor aerosolized to normals and individuals with cystic fibrosis.
McElvaney NG; Doujaiji B; Moan MJ; Burnham MR; Wu MC; Crystal RG
Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1056-60. PubMed ID: 8105734
[TBL] [Abstract][Full Text] [Related]
8. Effects of native and oxidation-resistant secretory leukoprotease inhibitor on cystic fibrosis sputum: inhibition of neutrophil elastase activity and of sputum-induced secretion from porcine tracheal submucosal glands.
Schuster A; Hansen G; Zubrod-Eichert C; Wahn V
Pediatr Res; 1996 Nov; 40(5):732-7. PubMed ID: 8910939
[TBL] [Abstract][Full Text] [Related]
9. Alpha-1 Antitrypsin Mitigates the Inhibition of Airway Epithelial Cell Repair by Neutrophil Elastase.
Garratt LW; Sutanto EN; Ling KM; Looi K; Iosifidis T; Martinovich KM; Shaw NC; Buckley AG; Kicic-Starcevich E; Lannigan FJ; Knight DA; Stick SM; Kicic A;
Am J Respir Cell Mol Biol; 2016 Mar; 54(3):341-9. PubMed ID: 26221769
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line.
Nakamura H; Yoshimura K; McElvaney NG; Crystal RG
J Clin Invest; 1992 May; 89(5):1478-84. PubMed ID: 1569186
[TBL] [Abstract][Full Text] [Related]
11. Secretory leukocyte protease inhibitor and lung inflammation in developing bronchopulmonary dysplasia.
Watterberg KL; Carmichael DF; Gerdes JS; Werner S; Backstrom C; Murphy S
J Pediatr; 1994 Aug; 125(2):264-9. PubMed ID: 7913723
[TBL] [Abstract][Full Text] [Related]
12. Elastase inhibitors of the respiratory tract.
Stockley RA; Morrison HM
Eur Respir J Suppl; 1990 Mar; 9():9s-15s. PubMed ID: 2340054
[TBL] [Abstract][Full Text] [Related]
13. Aerosol alpha 1-antitrypsin treatment for cystic fibrosis.
McElvaney NG; Hubbard RC; Birrer P; Chernick MS; Caplan DB; Frank MM; Crystal RG
Lancet; 1991 Feb; 337(8738):392-4. PubMed ID: 1671425
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil elastase/alpha 1-proteinase inhibitor complex levels decrease in plasma of cystic fibrosis patients during long-term oral beta-carotene supplementation.
Winklhofer-Roob BM; Schlegel-Haueter SE; Khoschsorur G; van't Hof MA; Suter S; Shmerling DH
Pediatr Res; 1996 Jul; 40(1):130-4. PubMed ID: 8798258
[TBL] [Abstract][Full Text] [Related]
15. Proteases and antiproteases in cystic fibrosis: pathogenetic considerations and therapeutic strategies.
Birrer P
Respiration; 1995; 62 Suppl 1():25-8. PubMed ID: 7792437
[TBL] [Abstract][Full Text] [Related]
16. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS
J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241
[TBL] [Abstract][Full Text] [Related]
17. Secretory leukocyte protease inhibitor in cystic fibrosis.
Stromatt SC
Agents Actions Suppl; 1993; 42():103-10. PubMed ID: 8102834
[TBL] [Abstract][Full Text] [Related]
18. Intravenous recombinant secretory leukoprotease inhibitor augments antineutrophil elastase defense.
Birrer P; McElvaney NG; Gillissen A; Hoyt RF; Bloedow DC; Hubbard RC; Crystal RG
J Appl Physiol (1985); 1992 Jul; 73(1):317-23. PubMed ID: 1354669
[TBL] [Abstract][Full Text] [Related]
19. Unopposed neutrophil elastase in bronchoalveolar lavage from transplant recipients with cystic fibrosis.
Nunley D; Dauber J; Iacono A; Keenan R; Zeevi A; Cornwell R; Love R; Meyer K; Soergel P; Peterson K
Am J Respir Crit Care Med; 1999 Jan; 159(1):258-61. PubMed ID: 9872847
[TBL] [Abstract][Full Text] [Related]
20. Use of secretory leukoprotease inhibitor to augment lung antineutrophil elastase activity.
Vogelmeier C; Gillissen A; Buhl R
Chest; 1996 Dec; 110(6 Suppl):261S-266S. PubMed ID: 8989162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]